Currently browsing: Items authored or edited by Dinar Kale https://orcid.org/0000-0002-2704-0542

70 items in this list.
Generated on Fri Mar 21 17:37:30 2025 GMT.

Book SectionTo Top

Joshi, Pallavi and Kale, Dinar (2024). Navigating the institutional gaps, mismatch, and neglect. In: Dauncey, Emily; Desai, Vandana and Potter, Robert B. eds. The Companion to Development Studies (4th Edition). London: Routledge, pp. 532–536.

Banda, Geoffrey; Wanjala, Cecilia; Vanduku, Veronica; Mugwagwa, Julius and Kale, Dinar (2024). Broken Supply Chains and Local Manufacturing Innovation: Responses to Covid-19 and Their Implications for Policy. In: Banda, Geoffrey; Mackintosh, Maureen; Karimi Njeru, Mercy; Songora Makene, Fortunata and Srinivas, Smita eds. Cancer Care in Pandemic Times: Building Inclusive Local Health Security in Africa and India. International political economy series. Cham: Palgrave Macmillan, pp. 25–46.

Banda, Geoffrey; Wanjala, Cecilia; Manduku, Veronica and Kale, Dinar (2024). Realistic Ambitions: Technology Transfer for Biologics Platform Technologies. In: Banda, Geoffrey; Mackintosh, Maureen; Karimi Njeru, Mercy; Sogora Makene, Fortunata and Srinivas, Smita eds. Cancer Care in Pandemic Times: Building Inclusive Local Health Security in Africa and India. International Political Economy Series (IPES). Palgrave Macmillan Cham, pp. 215–239.

Kale, Dinar; Srinivas, Smita and Banda, Geoffrey (2024). Emerging Business Models in Cancer Diagnostic Startups in India and Lessons for African Countries. In: Banda, Geoffrey; Mackintosh, Maureen; Karimi Njeru, Mercy; Songora Makene, Fortunata and Srinivas, Smita eds. Cancer Care in Pandemic Times: Building Inclusive Local Health Security in Africa and India. International Political Economy Series (IPES). Palgrave Macmillan Cham, pp. 191–213.

Joshi, Pallavi; Kale, Dinar and Wield, David (2024). Novel Approaches for Scaling up Engineering-Based Inclusive Innovation. In: Cooper, Adam; Trigos, Federico; Stjepandić,, Josef; Curran, Richard and Lazar, Irina eds. Engineering for Social Change. Advances in Transdisciplinary Engineering, 60. IOS Press, pp. 632–641.

Kale, Dinar (2017). Re-developing Knowledge Creation Capability: Innovating in Indian Pharmaceutical Industry under the TRIPS-Compliant Patent Regime. In: Little, Stephen E.; Go, Frank M. and Poon, Teresa Shuck-Ching eds. Global Innovation and Entrepreneurship: Challenges and Experiences from East and West. Cham: Palgrave Macmillan, pp. 229–247.

Papaioannou, Theo; Watkins, Andrew; Mugwagwa, Julius and Kale, Dinar (2015). Industry Associations and the Changing Politics of Making Medicines in South Africa. In: Mackintosh, Maureen; Banda, Geoffrey; Tibandebage, Paula and Wamae, Watu eds. Making Medicines in Africa: the Political Economy of Industrializing for Local Health. International Political Economy. Basingstoke: Palgrave Macmillan, pp. 261–277.

Banda, Geoffrey; Mugwagwa, Julius; Ndomondo-Sigonda, Margareth and Kale, Dinar (2015). Pharmaceutical Standards in Africa: The Road to Improvement and Their Role in Technological Capability Upgrading. In: Mackintosh, Maureen; Banda, Geoffrey; Wamae, Watu and Tibandebage, Paula eds. Making Medicines in Africa: The Political Economy of Industrializing for Local Health. Palgrave Macmillan, pp. 224–242.

Kale, Dinar (2012). India. In: Amann, Edmund and Cantwell, John eds. Innovative firms in emerging market countries, Volume 1. Oxford: Oxford University Press, pp. 148–191.

Kale, Dinar (2012). Transnational corporations: significance and impact. In: Papaioannou, Theo and Butcher, Melissa eds. International development in a changing world. London: Bloomsbury Academic, pp. 151–176.

Kale, Dinar; Little, Stephen and Hinton, Matt (2011). Reconfiguration of knowledge management practices in new product development- The case of the Indian pharmaceutical industry. In: Grant, Kenneth A. ed. Case Studies in Knowledge Management Research. Reading, UK: Academic Publishing International Ltd, pp. 102–119.

Fu, Xiaolan; Kaplinsky, Raphie and Kale, Dina (2011). Global manufactures prices: how do China’s exports compare? In: Fu, Xiaolan ed. China’s Role in Global Economic Recovery. Routledge Studies on the Chinese Economy. Abingdon, UK: Routledge, pp. 127–145.

Kale, Dinar and Little, Stephen (2010). Globalisation, migration and knowledge transfer: the reconfiguration of R&D capability in Indian pharmaceutical firms. In: Singh, P. and Verma, S. eds. Organizing and Managing in the Era of Globalization. New Delhi: Sage.

Kale, Dinar; Wield, David and Chataway, Jo (2008). Diffusion of knowledge through migration of scientific labour in India. In: Kumar, Krishna ed. Reverse Brain Drain: A Reality in Millennium. Human Resources Management. Hyderabad, India: ICFAI publications.

Kale, Dinar and Little, Stephen (2006). Knowledge generation in developing countries. In: Janardhan, Rao N. ed. Knowledge Based Economy - Country Perspectives. Economy. Hyderabad, India: ICFAI Publications.

Journal ItemTo Top

Kale, Dinar; Nabar, Janak; Garda, Laila and Tol, Varsha (2024). Exploring Inclusive MedTech Innovations for Resource-Constrained Healthcare in India. Innovation and Development, 14(3) pp. 539–561.

Srinivas, Smita and Kale, Dinar (2022). New approaches to learning and regulation in medical devices and diagnostics: insights from Indian cancer care. Innovation and Development, 13(2) pp. 361–384.

Rault-Chodankar, Yves-Marie and Kale, Dinar (2022). ‘Manufacturers without factories’ and economic development in the Global South: India’s pharmaceutical firms. Journal of Economic Geography, 23(3) pp. 319–341.

Banda, Geoffrey; Mugwagwa, Julius; Wanjala, Cecilia; Mackintosh, Maureen and Kale, Dinar (2021). Local manufacturing, local supply chains and health security in Africa: lessons from COVID-19. BMJ Global Health, 6(6), article no. e006362.

Kale, Dinar (2019). Mind the gap: Investigating the role of collective action in the evolution of Indian medical device regulation. Technology in Society, 59, article no. 101121.

Kale, Dinar (2019). From small molecule generics to biosimilars: Technological upgrading and patterns of distinctive learning processes in the Indian pharmaceutical industry. Technological Forecasting and Social Change, 145 pp. 370–383.

Kale, Dinar and Wield, David (2019). In search of the missing hand of "collaborative action": evidence from the Indian medical device industry. Innovation and Development, 9(1) pp. 1–23.

Kale, Dinar and Niosi, Jorge (2017). The special issue of the journal Technology Analysis & Strategic Management on biosimilar: capabilities, regulations and affordable healthcare. Technology Analysis and Strategic Management, 29(3) pp. 247–250.

Kale, Dinar and Huzair, Farah (2017). Heterogeneity in learning processes and the evolution of dynamic managerial capabilities as a response of emergence of biosimilar market: evidence from the Indian pharmaceutical industry. Technology Analysis and Strategic Management, 29(3) pp. 300–312.

Papaioannou, Theo; Watkins, Andrew; Mugwagwa, Julius and Kale, Dinar (2016). To Lobby or to Partner? Investigating the Shifting Political Strategies of Biopharmaceutical Industry Associations in Innovation Systems of South Africa and India. World Development, 78 pp. 66–79.

Harmon, Shawn H. E. and Kale, Dinar (2015). Regulating in developing countries: multiple roles for medical research and products regulation in Argentina and India. Technology in Society, 43 pp. 10–22.

Watkins, Andrew; Papaioannou, Theo; Mugwagwa, Julius and Kale, Dinar (2015). National innovation systems and the intermediary role of industry associations in building institutional capacities for innovation in developing countries: a critical review of the literature. Research Policy, 44(8) pp. 1407–1418.

Papaioannou, Theo; ; and (2015). Industry associations, health innovation systems and politics of development: the cases of India and South Africa. Business and Politics, 17(2) pp. 253–289.

Huzair, Farah and Kale, Dinar (2015). Biosimilars and the long game. Trends in Biotechnology, 33(5) pp. 250–252.

Kale, Dinar; Hanlin, Rebecca and Chataway, Joanna (2013). New drugs and health technologies for low-income populations: will the private sector meet the needs of low-income populations in developing countries? Innovation and Development, 3(1) pp. 121–137.

Kale, Dinar (2012). Sources of innovation and technology capability development in the Indian automobile industry. Institution and Economics, 4(2) pp. 121–150.

Kale, Dinar (2012). Innovative capability development in the Indian pharmaceutical industry. International Journal of Innovation and Technology Management, 9(2) p. 1250013.

Kale, Dinar (2010). Internationalisation strategies of Indian pharmaceutical firms. PharmaBuzz, 5(10) pp. 6–13.

Kale, Dinar (2010). The Distinctive Patterns of Dynamic Learning and inter-firm Differences in the Indian Pharmaceutical Industry. British Journal of Management, 21(1) pp. 223–238.

Kale, Dinar (2009). International migration, knowledge diffusion and innovation capacities in the Indian pharmaceutical industry. New Technology, Work and Employment, 24(3) pp. 260–276.

Athreye, Suma; Kale, Dinar and Ramani, Shyama V. (2009). Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector. Industrial and Corporate Change, 18(4) pp. 729–759.

Kaplinsky, Raphael; Chataway, Jo; Hanlin, Rebecca; Clark, Norman; Kale, Dinar; Muraguri, Lois; Papaioannou, Theo; Robbins, Peter and Wamae, Watu (2009). Below the radar: What does innovation in emerging economies have to offer other low-income economies? International Journal of Technology Management and Sustainable Development, 8(3) pp. 177–197.

Kale, Dinar; Wield, David and Chataway, Jo (2008). Diffusion of knowledge through migration of scientific labour in India. Science and Public Policy, 35(6) pp. 417–430.

Kale, Dinar and Wield, David (2008). Exploitative and Explorative Learning as a Response to the TRIPS Agreement in Indian Pharmaceutical Firms. Industry and Innovation, 15(1) pp. 93–114.

Archambault, Éric; Simonetti, Roberto; Côté, Grégoire and Kale, Dinar (2007). The dynamics of pharmaceutical patenting in India: Evidence from USPTO data. Technology Analysis and Strategic Management, 19(5) pp. 625–642.

Kale, Dinar and Little, Steve (2007). From imitation to innovation: the evolution of R&D capabilities and learning processes in the Indian pharmaceutical industry. Technology Analysis and Strategic Management, 19(5) pp. 589–609.

Chataway, Joanna; Kale, Dinar and Wield, David (2007). The Indian pharmaceutical industry before and after TRIPS. Technology Analysis and Strategic Management, 19(5) pp. 559–563.

Kale, Dinar and Little, Stephen E. (2007). Flows and cohesion: balancing capabilities across an expanded union. Mobilities, 2(1) pp. 99–108.

Kale, Dinar and Little, Stephen (2005). Knowledge generation in developing countries: a theoretical framework for exploring dynamic learning in high technology firms. Electronic Journal of Knowledge Management, 3(2) pp. 87–96.

Conference or Workshop ItemTo Top

Joshi, Pallavi; Kale, Dinar and Wield, David (2024). Novel approaches for scaling up engineering-based inclusive innovation. In: 31st International Conference on Transdisciplinary Engineering 2024, 9-11 Jul 2024, University College London, London, UK.

Mkwashi, Andrew; Kale, Dinar; Mugwagwa, Julius and Wield, David (2021). Analysing the co-evolution of embedded regulatory capabilities in firms and the state: the case of South Africa’s medical device sector. In: 17th Globelics International Conference 2021, 3-5 Nov 2021, Heredia, Costa Rica.

Papaioannou, Theo; Watkins, Andrew; Kale, Dinar and Mugwagwa, Julius (2016). Politics of Innovation and Development: the Role of Industry Associations in Integrating Political, Industrial and Health Systems in India and South Africa. In: 66th Political Studies Association Annual International Conference: Politics and the Good Life, 21-23 Mar 2016, Brighton, UK.

Papaioannou, Theo; Watkins, Andrew; Mugwagwa, Julius and Kale, Dinar (2016). Industry Associations and the Politics of Making Medicines in South Africa. In: 28th SASE Annual Meeting: Moral Economies, Economic Moralities, 24-26 Jun 2016, University of California Berkeley.

Kale, Dinar and Huzair, Farah (2015). New sources of growth under the TRIPS compliant patent regime for emerging country pharmaceutical industries?: Investigating the development of biosimilar capabilities in the Indian pharmaceutical sector. In: 13th Globelics International Conference, 23-25 Sep 2015, Havana, Cuba.

Kale, Dinar; Watkins, Andrew; Papaioannou, Theo and Mugwagwa, Julius (2015). Why Industry Associations Matter for Healthcare Industries in Emerging Countries: Evidence from the Indian Biotechnology and Medical Device Industries. In: 13th Globelics International Conference, 23-25 Sep 2015, Havana, Cuba.

Kale, Dinar and Mkwashi, Andrew (2015). Where will affordable medical devices for low-income populations come from? Emerging role of social technologies. In: Development Studies Association Annual Conference 2015: Global Development as Relationship: Dependence, Interdependence or Divide? 7th-8th September 2015, University of Bath, 7-8 Sep 2015, Bath.

Kale, Dinar and Huzair, Farah (2015). Heterogeneity in learning processes and the evolution of dynamic capabilities: evidence from the Indian pharmaceutical industry. In: DRUID15 Conference on the Relevance of Innovation, 15-17 Jun 2015, Rome, Italy.

Papaioannou, Theo; Watkins, Andrew and Kale, Dinar (2015). Are pharmaceutical industry associations an underutilised partner in health delivery governance and innovation systems in developing countries? In: Development Studies Association Annual Conference 2015, 7-8 Sep 2015, University of Bath.

Papaioannou, Theo; Watkins, Andrew; Mugwagwa, Julius and Kale, Dinar (2014). To lobby or to partner? Explaining the shifting political strategies of biopharmaceutical industry associations in South Africa and India. In: Development Studies Association Annual Conference 2014, 01 Nov 2014, London.

Kale, Dinar and Huzair, Farah (2014). Reconfiguration of competencies as a response to the emergence of disruptive new markets – evidence from Indian pharmaceutical firms. In: The International Joseph Schumpeter Society 15th ISS Conference: Foundations of Economic Change - Behaviour, Interaction and Aggregate Outcomes, 27-30 Jul 2014, Jena, Germany.

Papaioannou, Theo; Kale, Dinar; Mugwagwa, Julius and Watkins, Andrew (2014). The role of industry associations in health innovation and politics of development: the cases of South Africa and India. In: 15th International Conference of the International Joseph A. Schumpeter Society (ISS), 27-30 Jul 2014, Jena, Germany.

Watkins, Andrew; Papaioannou, Theo; Kale, Dinar and Mugwagwa, Julius (2014). National innovation systems, developing countries, and the role of intermediaries: a critical review of the literature. In: 15th International Conference of the International Joseph A. Schumpeter Society (ISS), 27-30 Jul 2014, Jena, Germany.

Kale, Dinar (2013). Regulation quagmire, inclusive innovations and arrested development: evidence from the Indian medical device industry. In: 11th Globelics International Conference, 11-13 Sep 2013, Ankara, Turkey.

Harmon, Shawn and Kale, Dinar (2012). A view against the grain? The role of regulation in Argentine and Indian bioscience innovation. In: 2nd Joint BISA-ISA International Conference, 20-22 Jun 2012, Edinburgh.

Kale, Dinar (2011). Co-evolution of policies and firm level technological capabilities in the Indian automobile industry. In: Atlanta Conference on Science and Innovation Policy, 2011, 13-17 Sep 2011, Atlanta, GA, USA.

Kale, Dinar (2011). In search of missing hand of 'state': the case of the Indian medical device industry. In: The 9th GLOBELICS (Global Network for the Economics of Learning, Innovation, and Competence Building Systems) International Conference: Creativity, innovation and Economic Development, 15-17 Nov 2011, Buenos Aires, Argentina.

Kale, Dinar (2010). Sources of innovation and technological capability development in the Indian automobile industry. In: 8th GLOBELICS International Conference, Making Innovation Work for Society: Linking, Leveraging and Learning, 01-03 Nov 2010, Kuala Lumpur, Malaysia.

Kale, Dinar (2010). Comparative analysis of Indian pharmaceutical and medical devices sector. In: Pharmaceuticals in Developing and Emerging Economies: Production, Innovation, and Access to Medicines in the wake of TRIPS, 17-19 Sep 2010, Hyderabad, India.

ThesisTo Top

Kale, Dinar (2005). Re-developing knowledge creation capability: Innovating in Indian pharmaceutical industry under the TRIPS regime. Doctor of Philosophy (PhD) thesis The Open University.

OtherTo Top

Banda, Geoffrey; Mackintosh, Maureen; Kale, Dinar; Mugwagwa, Julius and Wanjala, Cecilia (2021). Local manufacturing for health in Africa in the time of Covid-19: experience and lessons for policy. DEGRP, Overseas Development Institute.

Mackintosh, Maureen; Kale, Dinar; Orsenigo, Luigi and Simonetti, Roberto (2016). Submission to the United Nations Secretary General's High Level Panel on Access to Medicines. United Nations.

Kale, Dinar (2011). The changing role of key stakeholders in pharmaceutical value chain. Pharmaforum.

Huzair, Farah and Kale, Dinar (2011). Emergence of the Biosimilar Sector and Opportunities of Developing Country Suppliers. Innogen.

Kale, Dinar (2011). Cross-roads for pharma in India. pharmaforum.

Clark, Norman; Chataway, Joanna; Hanlin, Rebecca; Kale, Dinar; Kaplinsky, Raphael; Muraguri, Lois; Papaioannou, Theo; Robbins, Peter and Wamae, Watu (2009). Below the radar: What does innovation in the Asian driver economies have to offer other low income economies. Economic and Social Research Council.

Export

Subscribe to these results

get details to embed this page in another page Embed as feed [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0